Three cases of severe slow-release theophylline toxicity (plasma theophylline levels above 30 mg/l) in patients with severe chronic pulmonary disease are reported. Seizures were noted in all patients, and one had tachyarrhythmia. Two of the patients died. Several factors were present which may have impaired theophylline clearance, leading to toxic plasma levels. The mortality rate of theophylline intoxication being high, the initial doses should be sufficiently low to minimize the risk of adverse affects, and the best way to prevent theophylline toxicity is to monitor plasma concentrations. A management of patients with theophylline overdosage is suggested: oral administration of activated charcoal is the primary therapeutic measure; haemoperfusion or haemodialysis should be considered only in patients in whom conservative measures have failed.
Download full-text PDF |
Source |
---|
BMC Pediatr
October 2024
Department of Pharmacy, College of Medicine and Health Sciences, Adigrat University, P.O. Box 50, Adigrat, Tigrai, Ethiopia.
Nat Prod Bioprospect
September 2024
Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, 100050, People's Republic of China.
Int J Mol Sci
August 2024
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Front Cardiovasc Med
August 2024
Division of Cardiology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
RSC Adv
September 2024
Nanotechnology Engineering, Faculty of Advanced Technology and Multidiscipline, Universitas Airlangga Surabaya 60115 Indonesia
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!